Toxicity profiling and prioritization of plant-derived antimalarial agents

References

• World Health Organisation, World Malaria Report 2017, WHO, Geneva, Switzerland, 2017.
   Google Scholar
• B. Autino, A. Noris, R. Russo, and F. Castelli, Epidemiology of malaria in endemic areas, Mediterr. J. Hematol. Infect. Dis. 4 (2012), pp. e2012060. doi:10.4084/MJHID.2012.060.
   PubMedGoogle Scholar
• A. Amir, F.W. Cheong, J.R. de Silva, J.W.K. Liew, and Y.L. Lau, Plasmodium knowlesi malaria: Current research perspectives, Infect. Drug. Resist. 11 (2018), pp. 1145–1155. doi:10.2147/IDR.S148664.
   PubMed Web of Science ®Google Scholar
• K.M. Krishnan and K.C. Williamson, The proteasome as a target to combat malaria: Hits and misses, Transl. Res. 198 (2018), pp. 40–47. doi:10.1016/j.trsl.2018.04.007.
   PubMed Web of Science ®Google Scholar
• M. Prudêncio, A. Rodriguez, and M.M. Mota, The silent path to thousands of merozoites: The Plasmodium liver stage, Nat. Rev. Microbiol. 4 (2006), pp. 849–856. doi:10.1038/nrmicro1529.
   PubMed Web of Science ®Google Scholar
• S. Antinori, L. Galimberti, L. Milazzo, and M. Corbellino, Biology of human malaria plasmodia including Plasmodium knowlesi, Mediterr. J. Hematol. Infect. Dis. 4 (2012), pp. e2012013. doi:10.4084/MJHID.2012.013.
   PubMedGoogle Scholar
• J.M. Crutcher and S.L. Hoffman, Malaria, in Medical Microbiology, S. Baron, ed., 4th ed., University of Texas Medical Branch at Galveston, chapter 83, Galveston, 1996. Available at https://www.ncbi.nlm.nih.gov/books/NBK8584/.
   Google Scholar
• M.B. Wells and D.J. Andrew, “Salivary gland cellular architecture in the Asian malaria vector mosquito Anopheles stephensi”, Parasit Vect. 8 (2015), pp. 617. doi:10.1186/s13071-015-1229-z.
   PubMed Web of Science ®Google Scholar
• R.S. Nussenzweig, J. Vanderberg, H. Most, and C. Orton, Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei, Nature 216 (1967), pp. 160–162. doi:10.1038/216160a0.
   PubMed Web of Science ®Google Scholar
• A.J. Birkett, Status of vaccine research and development of vaccines for malaria, Vaccine 34 (2016), pp. 2915–2920. doi:10.1016/j.vaccine.2015.12.074.
   PubMed Web of Science ®Google Scholar
• S.J. Draper, B.K. Sack, C.R. King, C.M. Nielsen, J.C. Rayner, M.K. Higgins, C.A. Long, and R.A. Seder, Malaria vaccines: Recent advances and new horizons, Cell Host Microbe 24 (2018), pp. 43–56. doi:10.1016/j.chom.2018.06.008.
   PubMed Web of Science ®Google Scholar
• W.H. Tham, J.G. Beeson, and J.C. Rayner, Plasmodium vivax vaccine research – We’ve only just begun, Int. J. Parasitol. 47 (2017), pp. 111–118. doi:10.1016/j.ijpara.2016.09.006.
   PubMed Web of Science ®Google Scholar
• WHO, Malaria vaccine pilot launched in Malawi, 2019; Available at https://www.who.int/news-room/detail/23-04-2019-malaria-vaccine-pilot-launched-in-malawi (Date accessed: July 8, 2019).
   Google Scholar
• J.V. Pai-Dhungat, Caventou, Pelletier & history of quinine, J. Assoc. Phys. India 63 (2015), pp. 58.
   PubMedGoogle Scholar
• J. Achan, A.O. Talisuna, A. Erhart, A. Yeka, J.K. Tibenderana, F.N. Baliraine, P.J. Rosenthal, and U. D’Alessandro, Quinine, an old anti-malarial drug in a modern world: Role in the treatment of malaria, Malar. J. 10 (2011), pp. 144. doi:10.1186/1475-2875-10-144.
   PubMed Web of Science ®Google Scholar
• A.R. Butler, S. Khan, and E. Ferguson, A brief history of malaria chemotherapy, J. R. Coll. Physicians Edinb. 40 (2010), pp. 172–177.
   PubMedGoogle Scholar
• P.B. Bloland, Drug Resistance in Malaria, World Health Organization, Switzerland, WHO/CDS/CSR/DRS/2001.4, 2001.
   Google Scholar
• M.A. Biamonte, J. Wanner, and K.G. Le Roch, Recent advances in malaria drug discovery, Bioorg. Med. Chem. Lett. 23 (2013), pp. 2829–2843. doi:10.1016/j.bmcl.2013.03.067.
   PubMed Web of Science ®Google Scholar
• J. Yuan, K.C.C. Cheng, R.L. Johnson, R. Huang, S. Pattaradilokrat, A. Liu, R. Guha, D. Fidock, J. Inglese, T.E. Wellems, C.P. Austin, and X.Z. Su, Chemical genomic profiling for antimalarial therapies, response signatures and molecular targets, Science 333 (2011), pp. 724–729. doi:10.1126/science.1205216.
   PubMed Web of Science ®Google Scholar
• J. Devillers, Repurposing insecticides and drugs for the control of mosquitoes and their diseases, in Computational Design of Chemicals for the Control of Mosquitoes and Their Diseases, J. Devillers, ed., CRC Press, Boca Raton, USA, 2018, pp. 1–37.
   Google Scholar
• W. Karcher and J. Devillers, Practical Applications of Quantitative Structure-Activity Relationships (QSAR) in Environmental Chemistry and Toxicology, Kluwer Academic Publishers, Dordrecht, The Netherlands, 1990.
   Google Scholar
• Danishuddin, G. Madhukar, M.Z. Malik, and N. Subbarao, Development and rigorous validation of antimalarial predictive models using machine learning approaches, SAR QSAR Environ. Res. 30 (2019), pp. 543–560. doi:10.1080/1062936X.2019.1635526.
   PubMed Web of Science ®Google Scholar
• S. Rout and R.K. Mahapatra, In silico study of M18 aspartyl amino peptidase (M18AAP) of Plasmodium vivax as an antimalarial drug target, Bioorg. Med. Chem. 27 (2019), pp. 2553–2571. doi:10.1016/j.bmc.2019.03.039.
   PubMed Web of Science ®Google Scholar
• S. Kondaparla, U. Debnath, A. Soni, V.R. Dola, M. Sinha, K. Srivastava, S.K. Puri, and S.B. Katti, Synthesis, biological evaluation, and molecular modeling studies of chiral chloroquine analogues as antimalarial agents, Antimicrob. Agents Chemother. 62 (2018), pp. e02347–17. doi:10.1128/AAC.02347-17.
   PubMed Web of Science ®Google Scholar
• K. Inthajak, P. Toochinda, and L. Lawtrakul, Application of molecular docking and PSO-SVR intelligent approaches in antimalarial activity prediction of enantiomeric cycloguanil analogues, SAR QSAR Environ. Res. 29 (2018), pp. 957–974. doi:10.1080/1062936X.2018.1536678.
   PubMed Web of Science ®Google Scholar
• G. Kaur, E. Pavadai, S. Wittlin, and K. Chibale, 3D-QSAR modeling and synthesis of new fusidic acid derivatives as antiplasmodial agents, J. Chem. Inf. Model. 58 (2018), pp. 1553–1560. doi:10.1021/acs.jcim.8b00105.
   PubMed Web of Science ®Google Scholar
• M.N.N. Lima, C.C. Melo-Filho, G.C. Cassiano, B.J. Neves, V.M. Alves, R.C. Braga, P.V.L. Cravo, E.N. Muratov, J. Calit, D.Y. Bargieri, F.T.M. Costa, and C.H. Andrade, QSAR-driven design and discovery of novel compounds with antiplasmodial and transmission blocking activities, Front. Pharmacol. 9 (2018), pp. 146. doi:10.3389/fphar.2018.00146.
   PubMed Web of Science ®Google Scholar
• R.B. Aher and K. Roy, Exploring the structural requirements in multiple chemical scaffolds for the selective inhibition of Plasmodium falciparum calcium-dependent protein kinase-1 (PfCDPK-1) by 3D-pharmacophore modelling, and docking studies, SAR QSAR Environ. Res. 28 (2017), pp. 390–414. doi:10.1080/1062936X.2017.1326401.
   PubMed Web of Science ®Google Scholar
• P. Sidorov, B. Viira, E. Davioud-Charvet, U. Maran, G. Marcou, D. Horvath, and A. Varnek, QSAR modeling and chemical space analysis of antimalarial compounds, J Comput. Aided Mol. Des. 31 (2017), pp. 441–451. doi:10.1007/s10822-017-0019-4.
   PubMed Web of Science ®Google Scholar
• M. Ekor, The growing use of herbal medicines: Issues relating to adverse reactions and challenges in monitoring safety, Front. Pharmacol. 4 (2013), pp. 177. doi:10.3389/fphar.2013.00177.
   Web of Science ®Google Scholar
• P.A. Onguéné, F. Ntie-Kang, J.A. Mbah, L.L. Lifongo, J.C. Ndom, W. Sippl, and L.M. Mbaze, The potential of anti-malarial compounds derived from African medicinal plants, part III: An in silico evaluation of drug metabolism and pharmacokinetics profiling, Org. Med. Chem. Lett. 4 (2014), pp. 6. doi:10.1186/s13588-014-0006-x.
   PubMedGoogle Scholar
• S.A. Egieyeh, J. Syce, S.F. Malan, and A. Christoffels, Prioritization of anti-malarial hits from nature: Chemo-informatic profiling of natural products with in vitro antiplasmodial activities and currently registered anti-malarial drugs, Malar. J. 15 (2016), pp. 50. doi:10.1186/s12936-016-1087-y.
   PubMed Web of Science ®Google Scholar
• P.A. Onguéné, F. Ntie-Kang, L.L. Lifongo, J.C. Ndom, W. Sippl, and L.M. Mbaze, The potential of anti-malarial compounds derived from African medicinal plants, part I: A pharmacological evaluation of alkaloids and terpenoids, Malar. J. 12 (2013), pp. 449. doi:10.1186/1475-2875-12-449.
   PubMed Web of Science ®Google Scholar
• F. Ntie-Kang, P.A. Onguéné, L.L. Lifongo, J.C. Ndom, W. Sippl, and L.M. Mbaze, The potential of anti-malarial compounds derived from African medicinal plants, part II: A pharmacological evaluation of non-alkaloids and non-terpenoids, Malar. J. 13 (2014), pp. 81. doi:10.1186/1475-2875-13-81.
   PubMed Web of Science ®Google Scholar
• K. Kaur, M. Jain, T. Kaur, and R. Jain, Antimalarials from nature, Bioorg. Med. Chem. 17 (2009), pp. 3229–3256. doi:10.1016/j.bmc.2009.02.050.
   PubMed Web of Science ®Google Scholar
• M. Frederich, M.P. Hayette, M. Tits, P. De Mol, and L. Angenot, In vitro activities of strychnos alkaloids and extracts against Plasmodium falciparum, Antimicrob. Agents Chemother. 43 (1999), pp. 2328–2331. doi:10.1021/np980144f.
   PubMed Web of Science ®Google Scholar
• M. Frédérich, M.J. Jacquier, P. Thépenier, P. De Mol, M. Tits, G. Philippe, C. Delaude, L. Angenot, and M. Zèches-Hanrot, Antiplasmodial activity of alkaloids from various strychnos species, J. Nat. Prod. 65 (2002), pp. 1381–1386. doi:10.1021/np020070e.
   PubMed Web of Science ®Google Scholar
• W.H. Pan, X.Y. Xu, N. Shi, S.W. Tsang, and H.J. Zhang, Antimalarial activity of plant metabolites, Int. J. Mol. Sci. 19 (2018), pp. E1382. doi:10.3390/ijms19051382.
   PubMed Web of Science ®Google Scholar
• J. Bero, M. Frédérich, and J. Quetin-Leclercq, Antimalarial compounds isolated from plants used in traditional medicine, J. Pharm. Pharmacol. 61 (2009), pp. 1401–1433. doi:10.1211/jpp/61.11.0001.
   PubMed Web of Science ®Google Scholar
• R. Caniato and L. Puricelli, Review: Natural antimalarial agents (1995–2001), Crit. Rev. Plant Sci. 22 (2003), pp. 79–105. doi:10.1080/713610851.
   Web of Science ®Google Scholar
• A.M. Pohlit, R.B. Lima, G. Frausin, L.F. Silva, S.C. Lopes, C.B. Moraes, P. Cravo, M.V. Lacerda, A.M. Siqueira, L.H. Freitas-Junior, and F.T. Costa, Amazonian plant natural products: Perspectives for discovery of new antimalarial drug leads, Molecules 18 (2013), pp. 9219–9240. doi:10.3390/molecules18089219.
   PubMed Web of Science ®Google Scholar
• G. Bringmann, K. Messer, K. Wolf, J. Mühlbacher, M. Grüne, R. Brun, and A.M. Louis, Dioncophylline E from Dioncophyllum thollonii, the first 7,3ʹ-coupled dioncophyllaceous naphthylisoquinoline alkaloid, Phytochemistry 60 (2002), pp. 389–397. doi:10.1016/S0031-9422(02)00109-7.
   PubMed Web of Science ®Google Scholar
• A.B. Oliveira, M.F. Dolabela, F.C. Braga, R.L.R.P. Jacome, F.P. Varotti, and M.M. Povoa, Plant-derived antimalarial agents: New leads and efficient phythomedicines. Part I. Alkaloids, An. Acad. Bras. Ciênc. 81 (2009), pp. 715–740.
   PubMed Web of Science ®Google Scholar
• R. Batista, J. Silva Ade Jr, and A.B. de Oliveira, Plant-derived antimalarial agents: New leads and efficient phytomedicines. Part II. Non-alkaloidal natural products, Molecules 14 (2009), pp. 3037–3072. doi:10.3390/molecules14083037.
   PubMed Web of Science ®Google Scholar
• J. Bero and J. Quetin-Leclercq, Natural products published in 2009 from plants traditionally used to treat malaria, Planta Med. 77 (2011), pp. 631–640. doi:10.1055/s-0030-1250405.
   PubMed Web of Science ®Google Scholar
• M.H. Grace, C. Lategan, F. Mbeunkui, R. Graziose, P.J. Smith, I. Raskin, and M.A. Lila, Antiplasmodial and cytotoxic activities of drimane sesquiterpenes from Canella winterana, Nat. Prod. Commun. 5 (2010), pp. 1869–1872.
   PubMed Web of Science ®Google Scholar
• L.K. Basco, S. Mitaku, A.L. Skaltsounis, N. Ravelomanantsoa, F. Tillequin, M. Koch, and J. Le Bras, In vitro activities of furoquinoline and acridone alkaloids against Plasmodium falciparum, Antimicrob. Agents Chemother. 38 (1994), pp. 1169–1171. doi:10.1128/aac.38.5.1169.
   PubMed Web of Science ®Google Scholar
• M.F. Dolabela, S.G. Oliveira, J.M. Nascimento, J.M. Peres, H. Wagner, M.M. Póvoa, and A.B. de Oliveira, In vitro antiplasmodial activity of extract and constituents from Esenbeckia febrifuga, a plant traditionally used to treat malaria in the Brazilian Amazon, Phytomedicine 15 (2008), pp. 367–372. doi:10.1016/j.phymed.2008.02.001.
   PubMed Web of Science ®Google Scholar
• M.W. Muriithi, W.R. Abraham, J. Addae-Kyereme, I. Scowen, S.L. Croft, P.M. Gitu, H. Kendrick, E.N. Njagi, and C.W. Wright, Isolation and in vitro antiplasmodial activities of alkaloids from Teclea trichocarpa: In vivo antimalarial activity and X-ray crystal structure of normelicopicine, J. Nat. Prod. 65 (2002), pp. 956–959. doi:10.1021/np0106182.
   PubMed Web of Science ®Google Scholar
• A.O. Adeeko and O.A. Dada, Chloroquine reduces fertilizing capacity of epididyma sperm in rats, Afr. J. Med. Med. Sci. 27 (1998), pp. 63–64.
   PubMedGoogle Scholar
• S.A. Olumide and Y. Raji, Long-term administration of artesunate induces reproductive toxicity in male rats, J. Reprod. Infertil. 12 (2011), pp. 249–260.
   PubMedGoogle Scholar
• E.A. Erhirhie, Antimalarial therapies and infertility: A comprehensive review, Toxicol. Intern. 23 (2006), pp. 107–111. doi:10.22506/ti/2016/v23/i2/146684.
   Google Scholar
• Y.R. Niu, B. Wei, B. Chen, L.H. Xu, X. Jing, C.L. Peng, and T.Z. Ma, Amodiaquine-induced reproductive toxicity in adult male rats, Mol. Reprod. Dev. 83 (2016), pp. 174–182. doi:10.1002/mrd.22603.
   PubMed Web of Science ®Google Scholar
• S.C. Gbotolorun, O. Inikori, O.D. Bamisi, A.A.A. Osinubi, and A.O. Okanlawon, Quinine inhibits ovulation and produces oxidative stress in the ovary of cyclic Sprague-Dawley rats, Afr. Health Sci. 18 (2018), pp. 253–259. doi:10.4314/ahs.v18i2.8.
   PubMed Web of Science ®Google Scholar
• J. Devillers, N. Marchand-Geneste, A. Carpy, and J.M. Porcher, SAR and QSAR modeling of endocrine disruptors, SAR QSAR Environ. Res. 17 (2006), pp. 393–412. doi:10.1080/10629360600884397.
   PubMed Web of Science ®Google Scholar
• J. Devillers, Endocrine Disruption Modeling, CRC Press, Boca Raton, FL, 2009. doi:10.1201/9781420076363.
   Google Scholar
• P.I. Petkov, S. Temelkov, D.L. Villeneuve, G.T. Ankley, and O.G. Mekenyan, Mechanism-based categorization of aromatase inhibitors: A potential discovery and screening tool, SAR QSAR Environ. Res. 20 (2009), pp. 657–678. doi:10.1080/10629360903438347.
   PubMed Web of Science ®Google Scholar
• A.K. Saxena, J. Devillers, S.S. Bhunia, and E. Bro, Modelling inhibition of avian aromatase by azole pesticides, SAR QSAR Environ. Res. 26 (2015), pp. 757–782. doi:10.1080/1062936X.2015.1090749.
   PubMed Web of Science ®Google Scholar
• K. Kolšek, J. Mavri, M. Sollner Dolenc, S. Gobec, and S. Turk, Endocrine disruptome – An open source prediction tool for assessing endocrine disruption potential through nuclear receptor binding, J. Chem. Inf. Model. 54 (2014), pp. 1254–1267. doi:10.1021/ci400649p.
   PubMed Web of Science ®Google Scholar
• J. Devillers, E. Bro, and F. Millot, Prediction of the endocrine disruption profile of pesticides, SAR QSAR Environ. Res. 26 (2015), pp. 831–852. doi:10.1080/1062936X.2015.1104809.
   PubMed Web of Science ®Google Scholar
• A. Plošnik, M. Vračko, and J. Mavri, Computational study of binding affinity to nuclear receptors for some cosmetic ingredients, Chemosphere 135 (2015), pp. 325–334. doi:10.1016/j.chemosphere.2015.04.075.
   PubMed Web of Science ®Google Scholar
• J. Devillers, H. Devillers, E. Bro, and F. Millot, Expert judgment based multicriteria decision models to assess the risk of pesticides on reproduction failures of grey partridge, SAR QSAR Environ. Res. 28 (2017), pp. 889–911. doi:10.1080/1062936X.2017.1402449.
   PubMed Web of Science ®Google Scholar
• P. Ruiz, A. Sack, M. Wampole, S. Bobst, and M. Vracko, Integration of in silico methods and computational systems biology to explore endocrine-disrupting chemical binding with nuclear hormone receptors, Chemosphere 178 (2017), pp. 99–109. doi:10.1016/j.chemosphere.2017.03.026.
   PubMed Web of Science ®Google Scholar
• A. Usman and M. Ahmad, Computational study suggesting reconsideration of BPA analogues based on their endocrine disrupting potential estimated by binding affinities to nuclear receptors, Ecotoxicol. Environ. Saf. 171 (2019), pp. 154–161. doi:10.1016/j.ecoenv.2018.12.071.
   PubMed Web of Science ®Google Scholar
• A. Roncaglioni, N. Piclin, M. Pintore, and E. Benfenati, Binary classification models for endocrine disrupter effects mediated through the estrogen receptor, SAR QSAR Environ. Res. 19 (2008), pp. 697–733. doi:10.1080/10629360802550606.
   PubMed Web of Science ®Google Scholar
• K. Mansouri, A. Abdelaziz, A. Rybacka, A. Roncaglioni, A. Tropsha, A. Varnek, A. Zakharov, A. Worth, A.M. Richard, C.M. Grulke, D. Trisciuzzi, D. Fourches, D. Horvath, E. Benfenati, E. Muratov, E.B. Wedebye, F. Grisoni, G.F. Mangiatordi, G.M. Incisivo, H. Hong, H.W. Ng, I.V. Tetko, I. Balabin, J. Kancherla, J. Shen, J. Burton, M. Nicklaus, M. Cassotti, N.G. Nikolov, O. Nicolotti, P.L. Andersson, Q. Zang, R. Politi, R.D. Beger, R. Todeschini, R. Huang, S. Farag, S.A. Rosenberg, S. Slavov, X. Hu, and R.S. Judson, CERAPP: Collaborative estrogen receptor activity prediction project, Environ. Health Perspect. 124 (2016), pp. 1023–1033. doi:10.1289/ehp.1510267.
   PubMed Web of Science ®Google Scholar
• R.S. Judson, F.M. Magpantay, V. Chickarmane, C. Haskell, N. Tania, J. Taylor, M. Xia, R. Huang, D.M. Rotroff, D.L. Filer, K.A. Houck, M.T. Martin, N. Sipes, A.M. Richard, K. Mansouri, R.W. Setzer, T.B. Knudsen, K.M. Crofton, and R.S. Thomas, Integrated model of chemical perturbations of a biological pathway using 18 in vitro high-throughput screening assays for the estrogen receptor, Toxicol. Sci. 148 (2015), pp. 137–154. doi:10.1093/toxsci/kfv168.
   PubMed Web of Science ®Google Scholar
• A. Cassano, A. Manganaro, T. Martin, D. Young, N. Piclin, M. Pintore, D. Bigoni, and E. Benfenati, CAESAR models for developmental toxicity, Chem. Cent. J. 4 Suppl 1 (2010), pp. S4. doi:10.1186/1752-153X-4-S1-S4.
   PubMedGoogle Scholar
• D.K. Kochar, P. Agarwal, S.K. Kochar, R. Jain, N. Rawat, R.K. Pokharna, S. Kachhawa, and T. Srivastava, Hepatocyte dysfunction and hepatic encephalopathy in Plasmodium falciparum malaria, QJM 96 (2003), pp. 505–512. doi:10.1093/qjmed/hcg091.
   PubMed Web of Science ®Google Scholar
• A.C. Anand and P. Puri, Jaundice in malaria, J. Gastroenterol. Hepatol. 20 (2005), pp. 1322–1332. doi:10.1111/j.1440-1746.2005.03884.x.
   PubMed Web of Science ®Google Scholar
• R. Wielgo-Polanin, L. Lagarce, E. Gautron, B. Diquet, and P. Lainé-Cessac, Hepatotoxicity associated with the use of a fixed combination of chloroquine and proguanil, Int. J. Antimicrob. Agents 26 (2005), pp. 176–178. doi:10.1016/j.ijantimicag.2005.04.019.
   PubMed Web of Science ®Google Scholar
• M. Kamagaté, C.O. Diallo, D. Meless, T. Daubrey-Potey, A. Kakou, E. Balayssac, K.S. N’zue, J.C. Yavo, and H. Die-Kakou, Hépatonéphrites au cours du traitement du paludisme par les combinaisons thérapeutiques à partir d’une base de données de pharmacovigilance, Therapie 72 (2017), pp. 563–571. doi:10.1016/j.therap.2017.03.001.
   PubMedGoogle Scholar
• B. Terziroli Beretta-Piccoli, G. Mieli-Vergani, R. Bertoli, L. Mazzucchelli, C. Nofziger, M. Paulmichl, and D. Vergani, Atovaquone/proguanil-induced autoimmune-like hepatitis, Hepatol. Commun. 1 (2017), pp. 293–298. doi:10.1002/hep4.1039.
   PubMed Web of Science ®Google Scholar
• F. Pizzo, A. Lombardo, A. Manganaro, and E. Benfenati, A new structure-activity relationship (SAR) model for predicting drug-induced liver injury, based on statistical and expert-based structural alerts, Front. Pharmacol. 22 (2016), pp. 442. doi:10.3389/fphar.2016.00442.
   Google Scholar
• C.A. Lipinski, Lead- and drug-like compounds: The rule-of-five revolution, Drug Discov. Today Technol. 1 (2004), pp. 337–341. doi:10.1016/j.ddtec.2004.11.007.
   PubMedGoogle Scholar
• C.A. Lipinski, F. Lombardo, B.W. Dominy, and P.J. Feeney, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Adv. Drug Deliv. Rev. 64 (2012), pp. 4–17. doi:10.1016/j.addr.2012.09.019.
   Web of Science ®Google Scholar
• A. Leo, C. Hansch, and D. Elkins, Partition coefficients and their uses, Chem. Rev. 71 (1971), pp. 525–616. doi:10.1021/cr60274a001.
   Web of Science ®Google Scholar
• I. Moriguchi, S. Hirono, Q. Liu, Y. Nakagome, and Y. Matsushita, Simple method of calculating octanol/water partition coefficient, Chem. Pharm. Bull. 40 (1992), pp. 127–130. doi:10.1248/cpb.40.127.
   Web of Science ®Google Scholar
• J. Devillers, D. Domine, C. Guillon, and W. Karcher, Simulating lipophilicity of organic molecules with a back-propagation neural network, J. Pharm. Sci. 87 (1998), pp. 1086–1090. doi:10.1021/js980101j.
   PubMed Web of Science ®Google Scholar
• J. Devillers and D. Domine, Comparison of reliability of log P values calculated from a group contribution approach and from the autocorrelation method, SAR QSAR Environ. Res. 7 (1997), pp. 195–232. doi:10.1080/10629369708039131.
   Google Scholar
• J. Devillers, Calculation of octanol/water partition coefficients for pesticides: A comparative study, SAR QSAR Environ. Res. 10 (1999), pp. 249–262. doi:10.1080/10629369908039179.
   PubMed Web of Science ®Google Scholar
• J. Devillers, EVA/PLS versus autocorrelation/neural network estimation of partition coefficients, Perspect. Drug Discov. Design 19 (2000), pp. 117–131. doi:10.1023/A:100877160.
   Google Scholar
• A. Daina, O. Michielin, and V. Zoete, iLOGP: A simple, robust, and efficient description of n-octanol/water partition coefficient for drug design using the GB/SA approach, J. Chem. Inf. Model. 54 (2014), pp. 3284–3301. doi:10.1021/ci500467k.
   PubMed Web of Science ®Google Scholar
• T. Cheng, Y. Zhao, X. Li, F. Lin, Y. Xu, X. Zhang, Y. Li, R. Wang, and L. Lai, Computation of octanol-water partition coefficients by guiding an additive model with knowledge, J. Chem. Inf. Model. 47 (2007), pp. 2140–2148. doi:10.1021/ci700257y.
   PubMed Web of Science ®Google Scholar
• S.A. Wildman and G.M. Crippen, Prediction of physicochemical parameters by atomic contributions, J. Chem. Inf. Comput. Sci. 39 (1999), pp. 868–873. doi:10.1021/ci990307l.
   Google Scholar
• SILICOS-IT, Available at http://silicos-it.be.s3-website-eu-west-1.amazonaws.com/software/filter-it/1.0.2/filter-it.html.
   Google Scholar
• W.M. Meylan and P.H. Howard, Atom/fragment contribution method for estimating octanol-water partition coefficients, J. Pharm. Sci. 84 (1995), pp. 83–92. doi:10.1002/jps.2600840120.
   PubMed Web of Science ®Google Scholar
• A.K. Ghose and G.M. Crippen, Atomic physicochemical parameters for three-dimensional structure-directed quantitative structure-activity relationships I. Partition coefficients as a measure of hydrophobicity, J. Comput. Chem. 7 (1986), pp. 565–577. doi:10.1002/jcc.540070419.
   Web of Science ®Google Scholar
• V.N. Viswanadhan, M.R. Reddy, R.J. Bacquet, and M.D. Erion, Assessment of methods used for predicting lipophilicity: Application to nucleosides and nucleoside bases, J. Comput. Chem. 14 (1993), pp. 1019–1026. doi:10.1002/jcc.540140903.
   Web of Science ®Google Scholar
• A.K. Ghose, V.N. Viswanadhan, and J.J. Wendoloski, Prediction of hydrophobic (lipophilic) properties of small organic molecules using fragmental methods: An analysis of ALOGP and CLOGP methods, J. Phys. Chem. A. 102 (1998), pp. 3762–3772. doi:10.1021/jp980230o.
   Web of Science ®Google Scholar
• A. Daina, O. Michielin, and V. Zoete, SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules, Sci. Rep. 7 (2017), pp. 42717. doi:10.1038/srep42717.
   PubMed Web of Science ®Google Scholar
• W.J. Egan, K.M. Merz Jr, and J.J. Baldwin, Prediction of drug absorption using multivariate statistics, J. Med. Chem. 43 (2000), pp. 3867–3877. doi:10.1021/jm000292e.
   PubMed Web of Science ®Google Scholar
• A. Daina and V. Zoete, A BOILED-Egg to predict gastrointestinal absorption and brain penetration of small molecules, ChemMedChem 11 (2016), pp. 1117–1121. doi:10.1002/cmdc.201600182.
   PubMed Web of Science ®Google Scholar
• P. Ertl, B. Rohde, and P. Selzer, Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties, J. Med. Chem. 43 (2000), pp. 3714–3717. doi:10.1021/jm000942e.
   PubMed Web of Science ®Google Scholar
• L. Chedik, D. Mias-Lucquin, A. Bruyere, and O. Fardel, In silico prediction for intestinal absorption and brain penetration of chemical pesticides in humans, Int. J. Environ. Res. Public Health 14 (2017), pp. E708. doi:10.3390/ijerph14070708.
   PubMed Web of Science ®Google Scholar
• H.T. Le, C.M. Schaldach, G.L. Firestone, and L.F. Bjeldanes, Plant-derived 3,3ʹ-Diindolylmethane is a strong androgen antagonist in human prostate cancer cells, J. Biol. Chem. 278 (2003), pp. 21136–21145. doi:10.1074/jbc.M300588200.
   PubMed Web of Science ®Google Scholar
• C. Jiang, H.J. Lee, G.X. Li, J. Guo, B. Malewicz, Y. Zhao, E.O. Lee, H.J. Lee, J.H. Lee, M.S. Kim, S.H. Kim, and J. Lu, Potent antiandrogen and androgen receptor activities of an Angelica gigas-containing herbal formulation: Identification of decursin as a novel and active compound with implications for prevention and treatment of prostate cancer, Cancer Res. 66 (2006), pp. 453–463. doi:10.1158/0008-5472.CAN-05-1865.
   PubMed Web of Science ®Google Scholar
• G. Kallifatidis, J.J. Hoy, and B.L. Lokeshwar, Bioactive natural products for chemoprevention and treatment of castration-resistant prostate cancer, Semin. Cancer Biol. 40–41 (2016), pp. 160–169. doi:10.1016/j.semcancer.2016.06.003.
   PubMed Web of Science ®Google Scholar
• B. Weniger, C. Vonthron-Sénécheau, G.J. Arango, M. Kaiser, R. Brun, and R. Anton, A bioactive biflavonoid from Campnosperma panamense, Fitoterapia 75 (2004), pp. 764–767. doi:10.1016/j.fitote.2004.09.015.
   PubMed Web of Science ®Google Scholar
• B. Weniger, C. Vonthron-Sénécheau, M. Kaiser, R. Brun, and R. Anton, Comparative antiplasmodial, leishmanicidal and antitrypanosomal activities of several biflavonoids, Phytomedicine 13 (2006), pp. 176–180. doi:10.1016/j.phymed.2004.10.008.
   PubMed Web of Science ®Google Scholar
• R.J. Quinn, A.R. Carroll, N.B. Pham, P. Baron, M.E. Palframan, L. Suraweera, G.K. Pierens, and S. Muresan, Developing a drug-like natural product library, J. Nat. Prod. 71 (2008), pp. 464–468. doi:10.1021/np070526y.
   PubMed Web of Science ®Google Scholar
• J. Buckingham, Dictionary of Natural Products on CD-Rom, Chapman and Hall/CRC Press, London, 2005.
   Google Scholar
• T.Z. Linn, S. Awale, Y. Tezuka, A.H. Banskota, S.K. Kalauni, F. Attamimi, J.Y. Ueda, P.B. Asih, D. Syafruddin, K. Tanaka, and S. Kadota, Cassane- and norcassane-type diterpenes from Caesalpinia crista of Indonesia and their antimalarial activity against the growth of Plasmodium falciparum, J. Nat. Prod. 68 (2005), pp. 706–710. doi:10.1021/np0401720.
   PubMed Web of Science ®Google Scholar
• M. Hewitt and K. Przybylak, In silico models for hepatotoxicity, Meth. Mol. Biol. 1425 (2016), pp. 201–236. doi:10.1007/978-1-4939-3609-0_11.
   PubMedGoogle Scholar
• W.P. Walters, Going further than Lipinski’s rule in drug design, Expert Opin. Drug Discov. 7 (2012), pp. 99–107. doi:10.1517/17460441.2012.648612.
   PubMed Web of Science ®Google Scholar
• A.K. Ghose, V.N. Viswanadhan, and J.J. Wendoloski, A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases, J. Comb. Chem. 1 (1999), pp. 55–68.
   PubMed Web of Science ®Google Scholar
• D.F. Veber, S.R. Johnson, H.Y. Cheng, B.R. Smith, K.W. Ward, and K.D. Kopple, Molecular properties that influence the oral bioavailability of drug candidates, J. Med. Chem. 45 (2002), pp. 2615–2623. doi:10.1021/jm020017n.
   PubMed Web of Science ®Google Scholar
• I. Muegge, S.L. Heald, and D. Brittelli, Simple selection criteria for drug-like chemical matter, J. Med. Chem. 44 (2001), pp. 1841–1846. doi:10.1021/jm015507e.
   PubMed Web of Science ®Google Scholar
• E. Benfenati, A. Golbamaki, G. Raitano, A. Roncaglioni, S. Manganelli, F. Lemke, U. Norinder, E. Lo Piparo, M. Honma, A. Manganaro, and G. Gini, A large comparison of integrated SAR/QSAR models of the Ames test for mutagenicity, SAR QSAR Environ. Res. 29 (2018), pp. 591–611. doi:10.1080/1062936X.2018.1497702.
   PubMed Web of Science ®Google Scholar
• S. Majumdar, S.C. Basak, C.N. Lungu, M.V. Diudea, and G.D. Grunwald, Mathematical structural descriptors and mutagenicity assessment: A study with congeneric and diverse datasets, SAR QSAR Environ. Res. 29 (2018), pp. 579–590. doi:10.1080/1062936X.2018.1496475.
   PubMed Web of Science ®Google Scholar
• K.P. Singh, S. Gupta, and P. Rai, Predicting carcinogenicity of diverse chemicals using probabilistic neural network modeling approaches, Toxicol. Appl. Pharmacol. 272 (2013), pp. 465–475. doi:10.1016/j.taap.2013.06.029.
   PubMed Web of Science ®Google Scholar
• E. Mombelli and J. Devillers, Evaluation of the OECD (Q)SAR application toolbox and toxtree for predicting and profiling the carcinogenic potential of chemicals, SAR QSAR Environ. Res. 21 (2010), pp. 731–752. doi:10.1080/1062936X.2010.528598.
   PubMed Web of Science ®Google Scholar
• J. Devillers, E. Mombelli, and R. Samsera, Structural alerts for estimating the carcinogenicity of pesticides and biocides, SAR QSAR Environ. Res. 22 (2011), pp. 89–106. doi:10.1080/1062936X.2010.548349.
   PubMed Web of Science ®Google Scholar
• OECD, The report from the expert group on (quantitative) structure-activity relationships [(Q)SARs] on the principles for the validation of (Q)SARs, 2nd Meeting of the ad hoc Expert Group on QSARs, ENV/JM/MONO(2004)24, Number 49, OECD Headquarters, Paris, 20–21 September, 2004.
   Google Scholar
• P.A. Onguéné, C.V. Simoben, G.W. Fotso, K. Andrae-Marobela, S.A. Khalid, B.T. Ngadjui, L.M. Mbaze, and F. Ntie-Kang, In silico toxicity profiling of natural product compound libraries from African flora with anti-malarial and anti-HIV properties, Comput. Biol. Chem. 72 (2018), pp. 136–149. doi:10.1016/j.compbiolchem.2017.12.002.
   PubMed Web of Science ®Google Scholar
• N. Greene, P.N. Judson, J.J. Langowski, and C.A. Marchant, Knowledge-based expert systems for toxicity and metabolism prediction DEREK, StAR and METEOR, SAR QSAR. Environ. Res. 10 (1999), pp. 299–314. doi:10.1080/10629369908039182.
   PubMed Web of Science ®Google Scholar
• D.E. Pires, T.L. Blundell, and D.B. Ascher, pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures, J. Med. Chem. 58 (2015), pp. 4066–4072. doi:10.1021/acs.jmedchem.5b00104.
   PubMed Web of Science ®Google Scholar
• P. Rasoanaivo, C.W. Wright, M.L. Willcox, and B. Gilbert, Whole plant extracts versus single compounds for the treatment of malaria: Synergy and positive interactions, Malar. J. 15 (2011), pp. Sup. 1, S4. doi:10.1186/1475-2875-10-S1-S4.
   Google Scholar
• T.N. Wells, Natural products as starting points for future anti-malarial therapies: Going back to our roots? Malar. J. 15 (2011), pp. Sup. 1, S3. doi:10.1186/1475-2875-10-S1-S3.
   Google Scholar
• M. Feher and J.M. Schmidt, Property distributions: Differences between drugs, natural products, and molecules from combinatorial chemistry, J. Chem. Inf. Comput. Sci. 43 (2003), pp. 218–227. doi:10.1021/ci0200467.
   PubMedGoogle Scholar
• H. Ginsburg and E. Deharo, A call for using natural compounds in the development of new antimalarial treatments. An introduction, Malar. J. 10, (2011), pp. Sup. 1, S1. doi:10.1186/1475-2875-10-S1-S1.
   Web of Science ®Google Scholar
• J.F. Ferreira, D.L. Luthria, T. Sasaki, and A. Heyerick, Flavonoids from Artemisia annua L. as antioxidants and their potential synergism with artemisinin against malaria and cancer, Molecules 15 (2010), pp. 3135–3170. doi:10.3390/molecules15053135.
   PubMed Web of Science ®Google Scholar
• E.M. Williamson, Synergy and other interactions in phytomedicines, Phytomedicine 8 (2001), pp. 401–409. doi:10.1078/0944-7113-00060.
   PubMed Web of Science ®Google Scholar